Alpine Woods Capital Investors’s Zimmer Biomet ZBH Stock Holding History

Alpine Woods Capital Investors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,545	Closed	-$220K	–	229
2021 Q3	$220K	Sell	1,545 -1,185	-43%	-$174K	0.02%	215
2021 Q2	$426K	Sell	2,730 -206	-7%	-$33.4K	0.04%	191
2021 Q1	$456K	Sell	2,936 -412	-12%	-$63.8K	0.05%	191
2020 Q4	$501K	Sell	3,348 -14,626	-81%	-$2.07M	0.06%	180
2020 Q3	$2.38M	Sell	17,974 -1,854	-9%	-$242K	0.36%	91
2020 Q2	$2.3M	Sell	19,828 -978	-5%	-$113K	0.44%	72
2020 Q1	$2.04M	Hold	20,806	–	–	0.45%	65
2019 Q4	$3.02M	Hold	20,806	–	–	0.57%	46
2019 Q3	$2.77M	Hold	20,806	–	–	0.51%	43
2019 Q2	$2.38M	Sell	20,806 -103	-0.5%	-$12.1K	0.49%	51
2019 Q1	$2.59M	Sell	20,909 -412	-2%	-$46.8K	0.56%	39
2018 Q4	$2.15M	Sell	21,321 -515	-2%	-$57.9K	0.52%	43
2018 Q3	$2.79M	Sell	21,836 -103	-0.5%	-$12.2K	0.57%	42
2018 Q2	$2.37M	Sell	21,939 -101,043	-82%	-$11M	0.52%	57
2018 Q1	$13M	Hold	122,982	–	–	0.69%	52
2017 Q4	$14.4M	Hold	122,982	–	–	0.72%	42
2017 Q3	$14M	Buy	122,982 +103	+0.1%	+$11.9K	0.71%	44
2017 Q2	$15.3M	Sell	122,879 -12,360	-9%	-$1.47M	0.82%	34
2017 Q1	$16M	Sell	135,239 -206	-0.2%	-$23.3K	0.85%	28
2016 Q4	$13.6M	Buy	135,445 +1,648	+1%	+$177K	0.75%	39
2016 Q3	$16.9M	Sell	133,797 -3,399	-2%	-$420K	0.93%	19
2016 Q2	$16M	Sell	137,196 -34,093	-20%	-$3.86M	0.96%	22
2016 Q1	$17.7M	Buy	171,289 +7,107	+4%	+$688K	1.03%	18
2015 Q4	$16.4M	Buy	164,182 +54,590	+50%	+$5.34M	0.88%	33
2015 Q3	$9.99M	Buy	109,592 +74,675	+214%	+$7.49M	0.54%	56
2015 Q2	$3.7M	Hold	34,917	–	–	0.19%	133
2015 Q1	$3.98M	Sell	34,917 -113	-0.3%	-$12.9K	0.2%	126
2014 Q4	$3.86M	Buy	35,030 +51	+0.1%	+$5.38K	0.2%	124
2014 Q3	$3.42M	Buy	34,979 +8,549	+32%	+$841K	0.18%	124
2014 Q2	$2.67K	Buy	26,430 +17,150	+185%	+$1.67M	0.07%	140
2014 Q1	$852K	Hold	9,280	–	–	0.05%	228
2013 Q4	$840K	Buy	+9,280	New	+$803K	0.05%	220

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alpine Woods Capital Investors's ZBH Position: Q4 2021 in Review

Alpine Woods Capital Investors sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 1,545 shares — an estimated $220K sold.

Alpine Woods Capital Investors first reported a position in ZBH in Q4 2013 and held it in 32 quarters. The position peaked at $17.7M in Q1 2016. 999 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

Alpine Woods Capital Investors reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
Alpine Woods Capital Investors sold 1,545 Zimmer Biomet shares in Q4 2021, an estimated $220K.
Alpine Woods Capital Investors first reported a position in Zimmer Biomet in Q4 2013 and held it in 32 quarters.
Alpine Woods Capital Investors's Zimmer Biomet position peaked at $17.7M in Q1 2016.
999 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2021, filed 3 Feb 2022.